BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11555638)

  • 1. Interaction between the P14 residue and strand 2 of beta-sheet B is critical for reactive center loop insertion in plasminogen activator inhibitor-2.
    Saunders DN; Jankova L; Harrop SJ; Curmi PM; Gould AR; Ranson M; Baker MS
    J Biol Chem; 2001 Nov; 276(46):43383-9. PubMed ID: 11555638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the complex of plasminogen activator inhibitor 2 with a peptide mimicking the reactive center loop.
    Jankova L; Harrop SJ; Saunders DN; Andrews JL; Bertram KC; Gould AR; Baker MS; Curmi PM
    J Biol Chem; 2001 Nov; 276(46):43374-82. PubMed ID: 11546761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crystal structure of plasminogen activator inhibitor 2 at 2.0 A resolution: implications for serpin function.
    Harrop SJ; Jankova L; Coles M; Jardine D; Whittaker JS; Gould AR; Meister A; King GC; Mabbutt BC; Curmi PM
    Structure; 1999 Jan; 7(1):43-54. PubMed ID: 10368272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.
    Kjøller L; Martensen PM; Sottrup-Jensen L; Justesen J; Rodenburg KW; Andreasen PA
    Eur J Biochem; 1996 Oct; 241(1):38-46. PubMed ID: 8898886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the amino-acid composition of the shutter region of plasminogen activator inhibitor-1 for its transitions to latent and substrate forms.
    Hansen M; Busse MN; Andreasen PA
    Eur J Biochem; 2001 Dec; 268(23):6274-83. PubMed ID: 11733024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing nanosecond motions of plasminogen activator inhibitor-1 by time-resolved fluorescence anisotropy.
    Ko CW; Wei Z; Marsh RJ; Armoogum DA; Nicolaou N; Bain AJ; Zhou A; Ying L
    Mol Biosyst; 2009 Sep; 5(9):1025-31. PubMed ID: 19668868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide.
    Xue Y; Björquist P; Inghardt T; Linschoten M; Musil D; Sjölin L; Deinum J
    Structure; 1998 May; 6(5):627-36. PubMed ID: 9634700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partitioning of serpin-proteinase reactions between stable inhibition and substrate cleavage is regulated by the rate of serpin reactive center loop insertion into beta-sheet A.
    Lawrence DA; Olson ST; Muhammad S; Day DE; Kvassman JO; Ginsburg D; Shore JD
    J Biol Chem; 2000 Feb; 275(8):5839-44. PubMed ID: 10681574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1.
    Madsen JB; Dupont DM; Andersen TB; Nielsen AF; Sang L; Brix DM; Jensen JK; Broos T; Hendrickx ML; Christensen A; Kjems J; Andreasen PA
    Biochemistry; 2010 May; 49(19):4103-15. PubMed ID: 20387790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological detection of conformational neoepitopes associated with the serpin activity of plasminogen activator inhibitor type-2.
    Saunders DN; Buttigieg KM; Gould A; McPhun V; Baker MS
    J Biol Chem; 1998 May; 273(18):10965-71. PubMed ID: 9556575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The length of the reactive center loop modulates the latency transition of plasminogen activator inhibitor-1.
    Na YR; Im H
    Protein Sci; 2005 Jan; 14(1):55-63. PubMed ID: 15576554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activities.
    Di Giusto DA; Sutherland AP; Jankova L; Harrop SJ; Curmi PM; King GC
    J Mol Biol; 2005 Nov; 353(5):1069-80. PubMed ID: 16214170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.
    Olson ST; Swanson R; Day D; Verhamme I; Kvassman J; Shore JD
    Biochemistry; 2001 Oct; 40(39):11742-56. PubMed ID: 11570875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reactive-center loop of active PAI-1 is folded close to the protein core and can be partially inserted.
    Hägglöf P; Bergström F; Wilczynska M; Johansson LB; Ny T
    J Mol Biol; 2004 Jan; 335(3):823-32. PubMed ID: 14687577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1.
    Kvassman JO; Verhamme I; Shore JD
    Biochemistry; 1998 Nov; 37(44):15491-502. PubMed ID: 9799512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of the exosite residues of plasminogen activator inhibitor-1 to proteinase inhibition.
    Ibarra CA; Blouse GE; Christian TD; Shore JD
    J Biol Chem; 2004 Jan; 279(5):3643-50. PubMed ID: 14594804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering of conformations of plasminogen activator inhibitor-1. A crucial role of beta-strand 5A residues in the transition of active form to latent and substrate forms.
    Kirkegaard T; Jensen S; Schousboe SL; Petersen HH; Egelund R; Andreasen PA; Rodenburg KW
    Eur J Biochem; 1999 Jul; 263(2):577-86. PubMed ID: 10406969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural differences between active forms of plasminogen activator inhibitor type 1 revealed by conformationally sensitive ligands.
    Li SH; Gorlatova NV; Lawrence DA; Schwartz BS
    J Biol Chem; 2008 Jun; 283(26):18147-57. PubMed ID: 18436534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.
    Qureshi T; Goswami S; McClintock CS; Ramsey MT; Peterson CB
    Protein Sci; 2016 Feb; 25(2):499-510. PubMed ID: 26548921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A concerted structural transition in the plasminogen activator inhibitor-1 mechanism of inhibition.
    Blouse GE; Perron MJ; Thompson JH; Day DE; Link CA; Shore JD
    Biochemistry; 2002 Oct; 41(40):11997-2009. PubMed ID: 12356300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.